EGFR and lung cancer: Lung cancer is the leading cause of cancer death worldwide,1, 2 but treatment outcomes have been improved with the development of targeted treatments for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase, and c‐ros oncogene 1.